The coronavirus disease 2019 (COVID-19) has emerged as a global burden comprising cardiovascular and respiratory complications. In this opinion we would like to highlight the role of glycocalyx disturbance for endothelial cell infection possibly being the limiting factor to SARS-CoV-2 disease exacerbation.